TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
RAPT Therapeutics, Inc.
Rutgers, The State University of New Jersey
Fate Therapeutics
Incyte Corporation
MultiVir, Inc.